secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2022-11-18T23:59:59+00:00
Accession:  0001607062-22-000714
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma issues 101.9M Series A Preferred and 16.9M common shares in debt-for-equity swap
--------------------------------------------------------------------------------

- Issued 101,880,008 shares of Series A Preferred to satisfy $511,500 convertible debt and $253,816 accrued interest.
- Issued 16,912,946 common shares to satisfy $25,369 accrued interest on a convertible note.
- Total debt and interest converted: $790,685 ($511,500 principal + $279,185 interest).
- Securities issued under Section 4(a)(2) private placement exemption; no underwriters or commissions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000714/0001607062-22-000714-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000714/rgbp111822form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-22-000714

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer